1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, January 2016 (p8)

Biological Therapy Analysis & Statistics, January 2016 (p8)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

211-240 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Notch Signaling Pathway Inhibitors -Pipeline Insights, 2016

Notch Signaling Pathway Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Notch Signaling Pathway Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Notch Signaling ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2016

Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast activation protein (FAP) antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hematopoietic ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation
Global Orphan Drugs Market Outlook 2020

Global Orphan Drugs Market Outlook 2020

  • $ 1 500
  • Industry report
  • January 2016
  • by RNCOS

Orphan drugs, also called niche busters, are intended to treat patients suffering from very serious diseases for which no treatment or at least a satisfactory one, has so far been available. These diseases, ...

  • Industries : Biological Therapy
  • Countries : World
Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2016

Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Hedgehog Signaling Pathway Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hedgehog ...

  • Industries : Biological Therapy
Integrase Inhibitors -Pipeline Insights, 2016

Integrase Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Integrase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Integrase Inhibitors. The ...

  • Industries : Biological Therapy
Interferon Receptor Binders -Pipeline Insights, 2016

Interferon Receptor Binders -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interferon Receptor Binders-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon Recepto ...

  • Industries : Office Supply and Stationery, Office Goods, Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
OpportunityAnalyzer: B-Cell Non-Hodgkin’s Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024

OpportunityAnalyzer: B-Cell Non-Hodgkin’s Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024

  • $ 9 495
  • Industry report
  • January 2016
  • by Global Data

OpportunityAnalyzer: B-Cell Non-Hodgkin’s Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024 Summary Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Biological Therapy, Biotechnology
  • Countries : Japan, World
Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Glioblastoma Multiforme ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Melanoma - Pipeline Review, H2 2015

Melanoma - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Melanoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Melanoma - Pipeline Review, H2 2015’, provides an overview of the Melanoma’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Colorectal Cancer - Pipeline Review, H2 2015

Colorectal Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Colorectal Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H2 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Metastatic Breast Cancer - Pipeline Review, H2 2015

Metastatic Breast Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Metastatic Breast Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Breast Cancer’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Non-Hodgkin Lymphoma - Pipeline Review, H2 2015

Non-Hodgkin Lymphoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Non-Hodgkin Lymphoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Stroke - Pipeline Review, H2 2015

Stroke - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Stroke - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Stroke - Pipeline Review, H2 2015’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
HIV / AIDS - Pipeline Review, H2 2015

HIV / AIDS - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

HIV / AIDS - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H2 2015’, provides an overview of the HIV / AIDS’s therapeutic pipeline. This report provides ...

  • Industries : Pharmaceutical, Biopharmaceutical, Biotechnology, Research and Development, Drug and Medication
  • Countries : United States
Osteoarthritis - Pipeline Review, H2 2015

Osteoarthritis - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Osteoarthritis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H2 2015’, provides an overview of the Osteoarthritis’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Multiple Sclerosis - Pipeline Review, H2 2015

Multiple Sclerosis - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Multiple Sclerosis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H2 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Liver Cancer - Pipeline Review, H2 2015

Liver Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Liver Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H2 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Head And Neck Cancer - Pipeline Review, H2 2015

Head And Neck Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Head And Neck Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H2 2015’, provides an overview of the Head And Neck Cancer’s therapeutic ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Pancreatic Cancer - Pipeline Review, H2 2015

Pancreatic Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H2 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Ovarian Cancer - Pipeline Review, H2 2015

Ovarian Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Hepatitis C - Pipeline Review, H2 2015

Hepatitis C - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Hepatitis C - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H2 2015’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Prostate Cancer - Pipeline Review, H2 2015

Prostate Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H2 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Non-Small Cell Lung Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Non-Small Cell Lung Cancer’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Breast Cancer - Pipeline Review, H2 2015

Breast Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Breast Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H2 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2015

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2015’, provides an overview of ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.